ENTRADA THERAPEUTICS, INC. (TRDA) Return on equity 2023–2025
ENTRADA THERAPEUTICS, INC. (TRDA) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-47.0%FY2025 · since FY2023: -2.8% → -47.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -47.0% | -62.3 pp |
| FY2024 | 15.3% | +18.1 pp |
| FY2023 | -2.8% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice